Bone Marrow TransplantationBone MarrowHematologic NeoplasmsTransplantation, HomologousBone Marrow CellsGraft vs Host DiseaseTransplantation, AutologousLeukemiaWhole-Body IrradiationHematopoietic Stem Cell TransplantationTransplantation ConditioningBone and BonesAnemia, AplasticLiver TransplantationGraft SurvivalTransplantation ChimeraTissue DonorsHistocompatibility TestingBusulfanBone Marrow PurgingHematopoietic Stem CellsLeukemia, Myeloid, AcuteHistocompatibilityCyclophosphamidePrecursor Cell Lymphoblastic Leukemia-LymphomaTreatment OutcomeLeukemia, Myelogenous, Chronic, BCR-ABL PositiveRecurrenceTransplantation, IsogeneicBone Marrow DiseasesCombined Modality TherapyHematopoiesisKidney TransplantationLymphoma, Non-HodgkinLymphomaMice, Inbred C57BLTime FactorsImmunosuppressive AgentsRetrospective StudiesLeukemia, MyeloidMultiple MyelomaRadiation ChimeraStem Cell TransplantationMyelodysplastic SyndromesBone Marrow ExaminationHematologic DiseasesRemission InductionGraft RejectionAcute DiseaseSurvival AnalysisImmunocompromised HostHepatic Veno-Occlusive DiseaseBone RemodelingBone Marrow NeoplasmsTransplantation ImmunologyT-LymphocytesGraft vs Host ReactionImmunosuppressionLymphocyte DepletionNeoplasmsLeukocyte TransfusionHeart TransplantationAntineoplastic Combined Chemotherapy ProtocolsAspergillosisSevere Combined ImmunodeficiencyOpportunistic InfectionsSurvival RateChimeraHLA AntigensColony-Forming Units AssayCord Blood Stem Cell TransplantationFlow CytometryFatal OutcomeFollow-Up StudiesPrognosisHodgkin DiseaseAntineoplastic AgentsLeukocyte CountLung TransplantationCyclosporineActuarial AnalysisNeutropeniaLymphocyte TransfusionBone DensityGranulocyte Colony-Stimulating FactorNuclear FamilyCell DifferentiationMice, Inbred BALB COrgan TransplantationImmunophenotypingCarmustineGraft vs Tumor EffectPancytopeniaInfectionLeukemia, Myelomonocytic, AcuteGraft vs Leukemia EffectCytarabineAntibodies, MonoclonalCytomegalovirus InfectionsDisease-Free Survival